End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.79 CNY | +2.37% | -2.26% | -1.65% |
05-23 | Pacific Shuanglin Bio-pharmacy's Unit Gets Nod to Trial Intravenous Human Immunoglobulin | MT |
05-09 | Pacific Shuanglin Bio-pharmacy Subsidiary Gets Plasmapheresis License | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.65% | 2.7B | |
-2.00% | 90.27B | |
+1.32% | 40.12B | |
-15.73% | 31.75B | |
+62.93% | 26.6B | |
-21.28% | 14.41B | |
-8.50% | 12.92B | |
-44.07% | 11.3B | |
-13.06% | 11.44B | |
+4.87% | 8.87B |
- Stock Market
- Equities
- 000403 Stock
- News Pacific Shuanglin Bio-pharmacy Co., LTD
- Pacific Shuanglin Bio-pharmacy Sees Up to 160% Profit Jump in 2021